Yuva Biosciences Completes Successful Pre-Seed Round

Yuva Biosciences is a biotech company developing cosmeceuticals and therapeutics aimed at restoring mitochondrial function in the body. Preclinical research done by Dr. Keshav Singh, co-founder of Yuva, showed that improving mitochondrial function restored hair growth and reversed gray hair in an animal model. The company’s next step is to prove that this mechanism works in humans as well. Yuva Biosciences CEO Greg Schmergel recently told Follicle Thought that his company has successfully completed a pre-seed funding round of $2.6M, and is now starting to raise a seed round with a goal of $3M. Yuva is currently developing proprietary compounds to stimulate hair growth and reverse skin wrinkles. Schmergel also told Follicle Thought that he hopes to share a more detailed update about the company’s programs in hair and skin sometime early next year.